_edited.png)
RISK CONCERN
Investment Strategy, Risk Analysis, and Insights by Chartered Professionals
TDOC
Primary Facts
Health Information Services
Name:
-
Sector:
- 62578.00K
Industry:
30.18
CEO:
Mr. Jason Gorevic
Total Employees:
Mid Cap
Our Technological Advancement Rating
Our Rating:
0.002639021
-0.998717274
Teladoc Health, Inc. (XNYS:TDOC) In-Depth Stock/Fundamental/Options Analysis Today
Primary Targets/Price Insights
Previous Close ($) :
Teladoc Health, Inc. (XNYS:TDOC)
One Month Price Target:
Six Month Price Target :
$30.33
Likely Price in One Year's Time:
Ticker:
$31.05
Likely Trading Range Today Under (Normal Volatility)
$30.4
Price Upper limit ($) :
$31.93
Price Lower limit ($) :
Crash Risk Prep/Key Price Levels (High Volatility/Risk)
Price, as per data analysis, isn't likely to fall below:
Today:
P70
This week:
$27.37
This month :
$23.91
Other Primary facts
Market Cap:
161.66M
Market Cap Classification:
4.69B
Number of Shares
IPO Date:
B
Best/Worst Daily Performance (Last 3+ Years)
Highest Daily Appreciation:
-40.15%
$17.63
Worst Daily Decline:
Our Options Trading Entry Points
Iron Condor entry points for options expiring in 1 week's time
Low risk (<2%) entry points
Buy Call:
Sell Call:
Buy Put:
Sell Put:
$37.31
18.13%
$23.05
$43.21
Medium risk (<10%) entry points
Buy Call
Sell Call
$34.13
Buy Put:
Sell Put:
$17.15
$26.23
$35.39
These entry points can be used for other strategies, such as butterflies, straddles, etc.
Risk-Adjusted returns (Sharpe Ratio) of
Health Information Services
Sharpe Ratio:
TDOC, is amongst the top 40% lowest yielding stocks in terms of daily returns
Comparison:
1.03%
-1.857140297
Sharpe ratio is -185.71% lower than the industry
Average Returns/Yield of
Health Information Services
Daily returns:
1
Weekly returns:
-0.03%
Monthly returns:
-0.15%
Yearly returns:
-7.41%
Comparison of returns:
-2.460251617
Classification:
Average annual returns/yield (last 3 years) is -246.03% below industry average
Results of T-Test of Returns:
TDOC is a riskier investment compared to Nasdaq (IXIC)
Statistical test of Returns:
0.87
Volatility (measured by Standard Deviation)
Daily Volatility:
& is -138.62% lower than the market/S&P 500 average
Weekly Volatility:
4.51%
Monthly Volatility:
10.09%
Yearly Volatility:
20.18%
Volitlilty of last five days (Measured by Standard Deviation)
Average Volatility of this Week:
87.95%
-79.52%
Value at Risk Analysis (VaR)
Daily VaR:
Volatility in last five trading days has been -79.52% below long-term volatility
Weekly VaR:
-9.30%
Monthly VaR:
-20.79%
How Much Can the price of
Health Information Services
Decline in a Recession?
Likely price decline in a recession:
Base case (decline):
Risk of crash in next 6/12 months: Low (<25%)
Worst case (decline):
$18.97
This translates to price declining to:
-37%
This translates to price declining to:
>85%
Severe Crash Probability
-41.58%
What is Value at Risk (VaR)?
Risk Fundamentals
151.40%
TDOC is a 193.45% riskier investment compared to the market/S&P 500 & is 151.40% riskier than Nasdaq (IXIC)
TDOC is a 193.45% riskier investment compared to the market/S&P 500
Beta Examination of
Health Information Services
0.862
Expected beta in 1 year's time:
0.264
Expected beta in 3 year's time:
1.22
Unlevered (debt free) Beta:
Beta in relation to market/S&P 500--0.86
Beta in relation to Nasdaq (XNAS):
Returns are left (negative) skewed; mean returns are lower than median and mode returns
Beta in relation to all global stocks::
Beta is -0.92% below industry average
Beta Comparison & Analysis
Beta of competitors/peers::
0.736
-0.035
Average Industry Beta:
Beta is -3.51% lower than peers
-0.009195402
Sustainable Growth Rate Analysis
Sustainable growth rate for this stock/firm:
WACC is 2.12% above industry mean WACC
-
Alpha provided | Alpha Analysis
Alpha provided:
1.725
3.080
-10.480
Analysis of Cost of Capital of
Health Information Services
Equity cost of capital:
Alpha is -1048% below the market average
-0.006
Unlevered (without debt) cost of capital:
Equity cost of capital is -0.60% below industry mean WACC
Before-tax cost of debt:
7.73%
After-tax cost of debt:
4.02%
Overall debt rating:
3.17%
Weighted average cost of capital (WACC):
4.02%
2.12%
Key Per-Share Metrics & Analysis
Revenue per share:
-
Revenue growth rate per share of (3Y):
Price to sales ratio is -69.99% below the industry mean
-27.27%
EPS:
-
Expected Annual growth rate of EPS (3Y):
Price to free cash flow ratio is 19.90% higher than the industry
-46.24%
Free cash flow (FCF) per share:
Price to book ratio is -89.07% below the industry mean
Growth rate in R&D investment/expenditure is -780.45% lower than the industry
-
Debt per share
Debt repayment rate in last quarter: 0.00%
EBITDA per share
Each employee generates 3082% more EBITDA than industry average revenue per employee
Valuation Analysis Today of
Health Information Services
P/E Ratio:
-
P/E Ratio of Competitors/Peers:
0
-15725.41774
-1.001919186
-
-
P/S (Price to Sales ratio):
$13.26
-0.699858296
P/B (Price to book value ratio):
Price to sales ratio is -69.99% below the industry mean
-
0.198974107
Net income growth rate (3Y):
Annual revenue growth rate is -27.27% below industry average
-87.37%
Dividend Analysis
Net income growth rate is -87.37% lower than the industry average net income growth rate
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dividend History:
-
--$0.00
--$0.00
--$0.00
--$0.00
--$0.00
-
In-depth Debt & Leverage Analysis
Debt to equity ratio:
8.20%
Net debt to equity ratio:
The remaining useful life of property plant & equipment is: 2.9 years
Debt to assets ratio:
6.76%
Net debt to assets ratio:
17.20%
-58.49%
Ability to repay debt:
Interest coverage ratio:
Debt-to-asset ratio is -58.49% below industry average
-7.93
Looking forward:
Debt growth rate:
1.2x
-125.73%
0.00%
Analysis of Key Statistics
Correlation of price movement with the market:
6.695697696
Statistical significance of correlation:
-0.80%
Average Correlation of the industry with the market:
0.248
-34.16%
R Squared (percentage of price movement explained by movement of the market):
0.248
Correlation of price movement with Nasdaq (^IXIC):
0.061
Covariance of price movement with the market:
-0.096
Kurtosis
-0.25
10.163
Skewness of returns:
Returns have a significant fat-tails (leptokurtic), i.e., returns considerably higher or lower than the mean returns are more probable, compared to assets with normally distributed returns
-0.935
Fundamental Analysis & Dupont Analysis of
Health Information Services
Gross Profit Margin Ratio:
1.45B
Operating Profit Margin Ratio:
Net profit margin is 1702.63% higher than the industry
1688.71%
Net Profit Margin Ratio:
1.45B
Effective Tax Rate:
-0.88%
-0.969098191
Dupont Method
Net Profit Margin
Return on Equity Ratio (ROE):
×
ROA
=
×
Return on assets (ROA) is 3485.12% higher than the industry
2216.21%
Financial Leverage
Asset Turnover Ratio (ROA):
Operating profit margin is 1688.71% higher than the industry
3485.12%
Financial Leverage:
Interest coverage ratio is -793.08% less than industry average
Current Ratio:
Return on equity (ROE) is 2216.21% higher than the industry
-0.300574505
Cash Conversion Cycle (days):
$9.73
-0.716746336
Current ratio is -30.06% below industry average
Stock based compensation to net income ratio:
-
In-depth Efficiency Analysis
Revenue generated per employee:
Cash conversion cycle is -71.67% below industry average
0.00814006
EBITDA generated per employee:
Each employee generates 1% more revenue than industry average revenue per employee
30.8163199
Profit generated per employee:
-$41.15
1608%
Free cash flow (FCF) generated per employee:
Each employee generates 1608% more net income/profit than industry average revenue per employee
-1.971133258
Assets/Capital per employee
Each employee generates -197% less free cash flow than industry average revenue per employee
-1.971133258
Research & Development (R&D) Analysis
89.09%
-7.804515211
Competitors/Peer firms of
Health Information Services
$40.20
ELANCO ANIMAL HEALTH INCORPORATED (XNYS:ELAN)
TELEFLEX INCORPORATED (XNYS:TFX)
Qiagen NV (XNYS:QGEN)
CARDINAL HEALTH, INC. (XNYS:CAH)
SMITH & NEPHEW PLC (XNYS:SNN)
UNIVERSAL HEALTH SERVICES, INC. (XNYS:UHS)
DR.REDDY'S LABORATORIES LTD (XNYS:RDY)
HOA BINH RUBBER JOINT STOCK COMPANY (XSTC:HRC)
Current Analyst Ratings
-$43.03
Strong buy�17%
Buy�25%
Hold�13%
Sell�0%
Strong sell�0%
Income Statement
Period:
3/31/2022
Date:
Value
Revenue:
TTM
Cost of Revenue:
Gross Profit:
R&D Expense
General & Admin Expenses:
Selling, General & Admin Expenses
Sales and Marketing Expenses
Other Expenses :
Operating Expenses :
Cost & Expenses :
Interest Income:
Interest Expenses:
Depreciation & Amortization:
EBITDA:
Operating Income:
Other Income Expenses:
Income Before Tax:
Income Tax Expense:
Net Income:
Balance Sheet
Date:
Calendar Year:
Period:
Cash & Cash Equivalents:
Short Term Investments:
Cash & Short Term Investments:
Net Receivables:
Inventory:
Other Current Assets:
Total Current Assets:
PP&E:
Goodwill:
Intangible Assets:
Long Term Investments:
Tax Assets:
Other Non-Current Assets:
Total Non-Current Assets:
Other Assets:
Total Assets:
Accounts Payable:
Short Term Debt:
Tax Payables:
Deferred Revenue:
Other Current Liabilities:
Total Current Liabilities:
Long Term Debt:
Other Non-Current Liabilities:
Total Non Current Liabilities:
Other Liabilities:
Total Liabilities:
Common Stock:
Retained Earnings:
Accumulated Other Comprehensive Loss:
Other Total Stockholders' Equity:
Total Stockholders' Equity:
Total Liabilities and Stockholders' Equity:
Total Investments:
Total Debt:
Net Debt:
2.14B
691.32M
271%
321.29M
437.76M
1.14B
705.00M
214.51M
2.37B
-
63.72M
230.07M
-1178%
- 42514.00K
- 95849.00K
-1233%
- 42514.00K
Statement of Cash Flow
Date:
Period:
- 6674523.00K
Differed Income Tax :
62.88M
Stock Based Compensation :
- 2319.00K
Change in Working Capital :
60.44M
Accounts Receivables:
- 83634.00K
Other Working Capital:
492.00K
Other Non-Cash Items:
- 41340.00K
Net Cash Provided by Operating Activities:
6.61B
Investments in PP&E:
- 31747.00K
Net Acquisitions:
-
Purchases of Investments:
-
Sales/Maturities of Investments:
Other Investing Activities:
Net Cash Used for Investing Activities:
Debt Repayment:
Common Stock Issued:
Common Stock Repurchased:
Dividend Paid:
Other Financing Activities:
Net Cash Used Provided by Financing Activities:
Effect of FOREX on Changes in Cash:
Net Changes in Cash:
Cash at End of Period:
Cash at Beginning of Period:
Operating Cash Flow:
Capital Expenditure:
Free Cash Flow (FCF):
Value
3/31/2022
2022
Q1
836.44M
2.54M
838.99M
214.35M
70.65M
84.06M
1.21B
73.97M
7.90B
1.88B
-
-
26.63M
9.88B
-
11.09B
47.41M
13.05M
16.56M
83.85M
162.38M
306.69M
1.57B
9.70M
1.64B
-
1.95B
161.00K
- 8023279.00K
- 11424.0K
Value
1.68B
-
9.14B
11.09B
-
1.59B
-
-
- 27567.00K
- 27567.00K
-
-
-
-
2.82M
2.82M
- 538.00K
- 57036.00K
836.44M
893.48M
- 31747.00K
- 30831.00K
Our Proprietary Portfolio Rating
Our Rating:
55.14176459
Price Forecast/Expected Price in Next 5 Years of
Health Information Services
2023
2024
2025
2026
2027
32.08965
$32.09
$33.95
$35.92
$38.00